Loscalzo J, Inbal A, Handin R I
J Clin Invest. 1986 Oct;78(4):1112-9. doi: 10.1172/JCI112668.
von Willebrand protein was found to promote the incorporation of platelets into evolving fibrin thrombi. Using formalin-treated or fresh platelets, both the initial rate and extent of platelet incorporation into polymerizing fibrin were dependent on von Willebrand protein. von Willebrand protein was incorporated into evolving fibrin thrombi in parallel with platelets. Soluble fibrin monomer covalently linked to acrylonitrile beads (Matrex 102) bound von Willebrand protein specifically and saturably with an apparent approximate dissociation constant (KD) of 15 micrograms/ml. Glycocalicin, the water-soluble proteolytic fragment of glycoprotein Ib, bound to fibrin monomer in this system specifically and saturably, as well, with an apparent approximate KD of 5 micrograms/ml, but only in the presence of saturating concentrations of von Willebrand protein. These data demonstrate that the initial rate and extent of platelet incorporation into evolving fibrin thrombi are dependent on von Willebrand protein; von Willebrand protein serves as a link between polymerizing fibrin and platelet surface glycoprotein Ib; and von Willebrand protein binds to fibrin monomer and is thereby able to bind to platelet surface glycoprotein Ib in the absence of ristocetin.
研究发现血管性血友病因子可促进血小板整合到正在形成的纤维蛋白血栓中。使用经福尔马林处理的或新鲜的血小板,血小板整合到正在聚合的纤维蛋白中的初始速率和程度均依赖于血管性血友病因子。血管性血友病因子与血小板同时整合到正在形成的纤维蛋白血栓中。与丙烯腈珠(Matrex 102)共价连接的可溶性纤维蛋白单体可特异性且饱和性地结合血管性血友病因子,其表观解离常数(KD)约为15微克/毫升。糖蛋白Ib的水溶性蛋白水解片段糖钙蛋白,在该系统中也可特异性且饱和性地结合纤维蛋白单体,表观KD约为5微克/毫升,但仅在血管性血友病因子饱和浓度存在时才会如此。这些数据表明,血小板整合到正在形成的纤维蛋白血栓中的初始速率和程度依赖于血管性血友病因子;血管性血友病因子作为正在聚合的纤维蛋白与血小板表面糖蛋白Ib之间的连接物;并且血管性血友病因子可结合纤维蛋白单体,从而在不存在瑞斯托菌素的情况下能够结合血小板表面糖蛋白Ib。